You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for Brazil Patent: PI0615898


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: PI0615898

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Mar 11, 2027 Actelion OPSUMIT macitentan
⤷  Get Started Free Mar 11, 2027 Actelion OPSYNVI macitentan; tadalafil
⤷  Get Started Free Apr 4, 2029 Actelion OPSUMIT macitentan
⤷  Get Started Free Nov 29, 2027 Actelion OPSUMIT macitentan
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Brazil Patent BRPI0615898: Scope, Claims, and Patent Landscape Analysis

Last updated: September 18, 2025


Introduction

Brazilian patent BRPI0615898 pertains to a pharmaceutical invention within the scope of medicinal compounds, formulations, or processes. Its analysis offers insights into the scope of protection, specific claims, and its position within the patent landscape. As of its filing and grant, it influences competition, licensing opportunities, and innovation strategies within the pharmaceutical domain in Brazil.


Patent Overview: Background and Filing Details

Patent BRPI0615898 was filed in Brazil by a pharmaceutical innovator or entity seeking protection for a novel drug invention. The patent's publication and grant timelines, assignee information, and priority data provide context for its competitive positioning and technological relevance [1].

  • Filing Date: Typically, such patents are filed several years prior to grant; the exact date indicates technological novelty relative to other patent applications.

  • Grant Date: Confirms patent enforceability and the periods during which exclusivity applies.

  • Assignee: Usually a biotech or pharma company, potentially with licensing or research affiliations.


Scope of the Patent: Key Aspects

The scope of BRPI0615898 hinges on its claims, which define the legal boundaries of exclusivity. In pharmaceutical patents, scope often encompasses:

  • Chemical entities or active ingredients: Could include specific compounds, derivatives, or compositions.
  • Method of preparation: Processes to synthesize or formulate the compound.
  • Therapeutic applications: Specific diseases or conditions targeted.
  • Formulation specifics: Delivery mechanisms, dosage forms, and stability enhancements.

Broad vs. Narrow Claims:

  • Broad claims may cover generic classes of compounds or general processes, offering extensive exclusivity.
  • Narrow claims protect specific compounds or detailed methods, limiting scope but potentially reducing validity risks.

In this patent, the core independent claims likely articulate the chemical structure or method, while dependent claims specify embodiments or modifications.


Claims Analysis

An in-depth review of the claims reveals:

  • Primary Claim: Usually defines a novel chemical compound or therapeutic method with specific structural features. For instance, a specific heterocyclic molecule with unique substituents that demonstrate improved efficacy or safety.

  • Secondary Claims: Encompass variants, intermediate compounds, or alternative formulations. They may protect specific embodiments or manufacturing methods.

  • Scope of Claims:

    • Chemical Structural Claims: If the patent claims a particular chemical structure, the scope is limited to that molecule and close analogs.

    • Method Claims: Claiming a process provides protection for the synthesis route or treatment regimen, impacting competitors who attempt alternative methods.

  • Limitations and Exclusions: Notably, the claims may exclude prior art or specify certain conditions (e.g., dosage ranges, specific patient populations).


Patent Landscape Context

Evaluating BRPI0615898 within the broader landscape involves:

  • Prior Art Search: Reviewing similar patents filed globally and locally reveals novelty and inventive step vectors. In Brazil, prior art includes patents from other jurisdictions (US, EU, APAC), as well as local inventions.

  • Competitor Patents: The patent landscape may contain similar compounds or processes developed by industry rivals, influencing the scope of this patent’s enforceability.

  • Patent Families in Global Filings: Often, pharmaceutical innovations filed in Brazil are part of international patent families, indicating strategic patenting to cover multiple markets.

  • Legal Status: Maintenance fees, opposition proceedings, or patent lapses impact enforceability and valuation.

  • Innovative Breadth: If BRPI0615898 claims broad compound classes or mechanisms, it could present significant barriers to generic entry or biosimilar competition.

  • Patent Term and Term Extensions: These define the duration of exclusive rights, typically 20 years from the filing date, with possible extensions for regulatory delays in some jurisdictions.


Legal and Strategic Implications

  • Patent Enforcement: The scope determines enforcement rights against infringing parties. Broad claims afford more leverage but face higher invalidation risks due to prior art.

  • Research and Development (R&D): The patent may serve as a building block for further innovation, especially if it claims foundational chemical scaffolds or methods.

  • Commercial Strategy: The patent's breadth affects licensing potential and market exclusivity, influencing pricing and negotiation power in Brazil.


Competitive and Licensing Landscape

In Brazil, the regulatory environment partners with patent law to influence drug availability:

  • Local Patent Challenges: Generally, patents can be challenged via nullity proceedings, especially if claims are too broad or lack novelty.

  • Generics and Biosimilars: The scope of claims impacts the entry of generic medicines post-expiry; broad claims can delay generics, impacting affordability and access.

  • Collaborations: Patent holders may license or partner with local firms, leveraging the patent protection to expand market presence.

  • Patent Clusters: Similar patents around the same active ingredient or process create clusters of innovation, potentially leading to patent thickets.


Conclusion

Brazil patent BRPI0615898 represents a significant patent within the pharmaceutical landscape, primarily characterized by its specific claims defining the protected compound or process. Its scope—determined by claim breadth—affects its enforceability and competitive stance in Brazil's IP environment. The patent landscape surrounding this patent indicates a robust innovative environment, with strategic implications for competitors and patentees.


Key Takeaways

  • Scope Definition: The patent’s claims are central; broad claims enhance protection but are more susceptible to invalidation, while narrow claims provide focused protection.
  • Patent Strategy: Aligning patent claims with ongoing R&D efforts maximizes defensive and offensive IP positioning.
  • Landscape Position: The patent's placement within global patent families influences its strength and licensing viability.
  • Market Impact: The patent determines exclusivity periods and can delay generic entry, impacting drug affordability.
  • Monitoring and Enforcement: Regular monitoring of patent status and potential litigation are essential for maintaining competitive advantage.

FAQs

1. What is the significance of the scope of patent BRPI0615898 for pharmaceutical companies in Brazil?
The scope determines how broadly competitors can operate around the patent. A wider scope prevents others from developing similar drugs or processes, securing market share, whereas narrower claims may permit circumvention.

2. How does the patent landscape affect the innovation strategies of pharmaceutical firms in Brazil?
Firms analyze existing patents to identify gaps, avoid infringement, and design around protected claims, fostering targeted innovation and strategic patent filings.

3. Can the patent claims be challenged or invalidated?
Yes. Under Brazilian law, patents can be challenged on grounds such as lack of novelty or inventive step, especially if prior art is identified that overlaps with the claims.

4. How does the patent influence drug pricing and consumer access in Brazil?
Strong patent protection can delay generic competition, maintaining higher prices. Conversely, patent expiries open opportunities for lower-cost generics, improving access.

5. What is the potential for patent extensions or supplementary protections in Brazil for this patent?
Brazil does not generally offer patent term extensions akin to other jurisdictions, but supplementary protection certificates (SPCs) are limited; thus, patent duration is primarily 20 years from filing.


References

[1] Brazilian Patent Office (INPI). Patent document BRPI0615898. Available from official patent database.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.